Carnosine, diabetes and Alzheimer’s disease

References

• Maher P, Schubert D. Metabolic links between diabetes and Alzheimer’s disease. Expert Rev. Neurother.9(5), 617–630 (2009).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Accumulation of altered proteins and ageing: causes and effects. Expt. Gerontol.41, 464–473 (2006).
   PubMed Web of Science ®Google Scholar
• Bonfanti L, Peretto P, de Marchis S, Fasolo A. Carnosine-related dipeptides in the mammalian brain. Prog. Neurobiol.59, 333–353 (1999).
   PubMed Web of Science ®Google Scholar
• Quinn PJ, Boldyrev AA, Formazuyk VE. Carnosine: its properties, functions and potential therapeutic applications. Mol. Aspects Med.13, 379–444 (1992).
   PubMed Web of Science ®Google Scholar
• Bauer K. Carnosine and homocarnosine, the forgotten, enigmatic peptides of the brain. Neurochem. Res.30, 1339–1345 (2005).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Would carnosine or a carnivorous diet help suppress aging and associated pathologies? Ann. NY Acad. Sci.1067, 369–374 (2006).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Glycation, ageing and carnosine: are carnivorous diets beneficial? Mech. Ageing Dev.126, 1034–1039 (2005).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Could carnosine or related structures suppress Alzheimer’s disease? J. Alzheimers Dis.11, 229–240 (2007).
   PubMed Web of Science ®Google Scholar
• Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine and anserine present in muscle and brain. Proc. Natl Acad. Sci. USA95, 2175–2179 (1988).
   Google Scholar
• Bogardus SL, Boissonneault GA. Carnosine inhibits in vitro low-density lipoprotein oxidation. Nutr. Res.20, 967–976 (2000).
   Web of Science ®Google Scholar
• Calabrese V, Coombrita C, Guagliano E et al. Protective effect of carnosine during nitrosactive stress in astroglial cell cultures. Neurochem. Res.30, 797–807 (2005).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Michaelis J, Syrris P. Non-enzymic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. FEBS Lett.371, 81–85 (1995).
   PubMed Web of Science ®Google Scholar
• Yan H, Harding JJ. Carnosine protects against the inactivation of esterase induced by glycation and a steroid. Biochim. Biophys. Acta1741, 120–126 (2005).
   PubMed Web of Science ®Google Scholar
• Seidler NW. Carnosine prevents glycation-induced changes in electrophoretic mobility of aspartate aminotransferase. J. Biochem. Mol. Toxicol.14, 215–220 (2000).
   PubMed Web of Science ®Google Scholar
• Baran EL. Metal complexes of carnosine. Biochem. (Moscow)65, 789–797 (2000).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Chana H. Carnosine protects proteins against methylglyoxal-mediated modifications. Biochem. Biophys. Res. Commun.248, 28–32 (1998).
   PubMed Web of Science ®Google Scholar
• Brownson C, Hipkiss AR. Carnosine reacts with a glycated protein. Free Radic. Biol. Med.28, 1564–1570 (2000).
   PubMed Web of Science ®Google Scholar
• Battah S, Ahmed N, Thornalley PJ. Novel anti-glycation therapeutic agents: glyoxalase-1-mimetics. Int. Congr. Ser.1245, 107–111 (2002).
   Google Scholar
• Hipkiss AR, Preston JE, Himsworth DT, Worthington VC, Abbott NJ. Protective effects of carnosine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci. Lett.238, 135–138 (1997).
   PubMed Web of Science ®Google Scholar
• Aldini G, Carini M, Beretta G, Bradamante S, Facino RB. Carnosine is a quencher of 4-hydroxynonenal: though what is the mechanism of reaction? Biochem. Biophys. Res. Commun.298, 699–706 (2002).
   PubMed Web of Science ®Google Scholar
• Carini M, Aldini G, Beretta G, Arlandini E, Facino RM. Acrolein-sequestering ability of endogenous dipeptides: characterization of carnosine and homocarnosine/acrolein adducts by electrospray ionization tandem mass spectrometry. J. Mass Spec.38, 996–1006 (2003).
   PubMed Web of Science ®Google Scholar
• Aldini G, Maffei-Fracino R, Beretta G, Carini M. Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. BioFactors24, 77–87 (2005).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Preston JE, Himsworth DTM et al. Pluripotent protective effects of carnosine, a naturally-occurring dipeptide. Ann. NY Acad. Sci.854, 37–53 (1998).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR, Brownson C, Carrier MJ. Carnosine, the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech. Ageing Dev.122, 1431–1445 (2001).
   PubMed Web of Science ®Google Scholar
• McFarland GA, Holliday R. Retardation of senescence in cultured human diploid fibroblasts by carnosine. Exp. Cell Res.212, 167–175 (1994).
   PubMed Web of Science ®Google Scholar
• McFarland GA, Holliday R. Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured diploid fibroblasts. Exp. Geront.34, 35–45 (1999).
   PubMed Web of Science ®Google Scholar
• Yuneva MO, Bulygina ER, Gallant SC, et al. Effect of carnosine on age-induced changes in senescence-accelerated mice. J. Anti Aging Med.2, 337–342 (1999).
   Google Scholar
• Yuneva AO, Kramarenko GG, Vetreshchak TV, Gallant S, Boldyrev AA. Effect of carnosine on Drosophila melanogaster lifespan. Bull. Expt. Biol. Med.133, 559–561 (2002).
   PubMed Web of Science ®Google Scholar
• Preston JP, Hipkiss AR, Himsworth DJT, Romero IA, Abbott JN. Toxic effects of b-amyloid (25–35) on immortalised rat brain endothelial cells: protection by carnosine, homocarnosine and β-alanine. Neurosci. Lett.242, 105–108 (1998).
   PubMed Web of Science ®Google Scholar
• Boldyrev AA, Koudinov A, Berezov T, Carpenter DO. Amyloid-β induced cell death is independent of free radicals. J. Alzheimer Dis.6, 633–638 (2004).
   PubMed Web of Science ®Google Scholar
• Fu Q, Dai H, Hu W et al. Carnosine protects against Aβ42-induced neurotoxicity in differentiated rat PC12 cells. Cell. Mol. Neurobiol.28, 307–316 (2008).
   PubMed Web of Science ®Google Scholar
• Lee Y, Hsu C, Lin K, Yin M. Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur. J. Pharmacol.512, 145–150 (2005).
   Google Scholar
• Sauerhoefer S, Yuan G, Braun GS et al.L-carnosine, a substrate for carnosinase-1, influences glucose metabolism. Diabetes56, 2425–2432 (2007).
   PubMed Web of Science ®Google Scholar
• Janssen B, Hohenadel D, Brinkkoeter P et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes54, 2320–2327 (2005).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Hicks PJ, Sale MM et al. A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol. Dial. Transplant.22, 1131–1135 (2007).
   PubMed Web of Science ®Google Scholar
• Dobrota D, Fedorova T, Stvolinsky SL et al. Carnosine protects the brain of rats and Mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem. Res.30, 1283–1288 (2005).
   PubMed Web of Science ®Google Scholar
• Fouad AA, El-Rehany MA, Maghraby HK. The hepatoprotective effect of carnosine against ischemia/reperfusion liver injury in rats. Eur. J. Pharmacol.572, 61–68 (2007).
   PubMed Web of Science ®Google Scholar
• Fujii T, Takaoka M, Tsuruoka N, Kiso Y, Matsumura Y. Dietary supplemention with L-carnosine prevents ischemia/reperfusion renal injury in rats. Biol. Pharm. Bull.28, 361–363 (2005).
   PubMed Web of Science ®Google Scholar
• Gallant S, Kukley M, Stvolinsky S, Bulgina E, Boldyrev AA. Effect of carnosine on rats under experimental ischemia. Tohoku J. Exp. Med.191, 85–99 (2000).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. Carnosine, a protective anti-ageing peptide? Int. J. Biochem. Cell Biol.30, 863–868 (1998).
   PubMed Web of Science ®Google Scholar
• Boldyrev AA, Gallant SC, Sukhich GT. Carnosine, the protective, anti-ageing peptide. Biosci. Rep.19, 581–587 (1999).
   PubMed Web of Science ®Google Scholar
• Hipkiss AR. On the enigma of carnosine’s anti-ageing actions. Expt. Gerontol.44, 237–242 (2009).
   PubMed Web of Science ®Google Scholar
• Stuerenburg HJ, Kunze K. Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle and rat muscles. Arch. Geront. Geriat.29, 107–113 (1999).
   PubMed Web of Science ®Google Scholar
• Johnson P, Hammer JL. Histidine dipeptide levels in aging and hypertensive rat skeletal and cardiac muscles. Comp. Biochem. Physiol. B Biochem. Mol. Biol.103, 981–984 (1992).
   PubMed Web of Science ®Google Scholar
• Tallon MJ, Harris RC, Maffulli N, Tarnopolsky MA. Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects. Biogerontology8, 129–137 (2007).
   PubMed Web of Science ®Google Scholar
• Jansen EEW, Gibson KM, Shigematsu Y, Jakobs C, Verhoeven NM. A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography-tandem mass spectrometry. J. Chromatog. B Analyt. Technol. Biomed. Life Sci.830, 196–200 (2006).
   PubMed Web of Science ®Google Scholar
• Huang Y, Duan J, Chen H, Chen M, Chen G. Separation and determination of carnosine-related peptides using capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis26, 593–599 (2005).
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Nakamura K, Inoue H, Kikushi S, Takeuchi M. Serum and cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer’s disease. Med. Hyp.64, 1205–1207 (2005).
   PubMed Web of Science ®Google Scholar
• Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Munch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer’s disease and link to cognitive impairment. J. Neurochem.92, 255–263 (2005).
   PubMed Web of Science ®Google Scholar
• Shuvaev VV, Laffont I, Serot M, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid in Alzheimer’s disease. Neurobiol. Aging22, 397–402 (2001).
   PubMed Web of Science ®Google Scholar
• Harris RC, Tallon MJ, Dunnett M et al. The absorption of orally supplied β-alanine and its effects on muscle carnosine synthesis in human vastus lateralis. Amino Acids30, 279–289 (2006).
   PubMed Web of Science ®Google Scholar
• Barbizhayev MA. Ocular drug metabolism of the bioactivating antioxidant N-acetylcarnosine for vision in ophthalmic progrug and codrug design and delivery. Drug Dev. Ind. Pharm.34, 1071–1089 (2008).
   PubMed Web of Science ®Google Scholar
• Petroff OA, Hyder F, Rothman DL, Mattson FH. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate. Epilepsia47, 495–498 (2006).
   PubMed Web of Science ®Google Scholar
• Petroff OA, Mattson RH, Behar KL, Hyder F, Rothman DL. Vigabatrin increases human brain homocarnosine and improves seizure control. Ann. Neurol.44, 948–952 (1998).
   PubMed Web of Science ®Google Scholar
• Hughes SE, Evason K, Xiong C, Kornfeld K. Genetic and pharmacological factors that influence reproductive aging in nematodes. PLoS Genet.3, 254–265 (2007).
   Web of Science ®Google Scholar
• Evason K, Huang C, Yamben I, Covey DF, Kornfield K. Anticonvulsant medications extend worm life-span. Science307, 258–262 (2005).
   PubMed Web of Science ®Google Scholar